MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Progressive supranuclear palsy presenting with corticobasal syndrome: a case report

    M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)

    Objective: Clinical description and interpretation of complementary diagnostic exams of a patient with probable PSP with corticobasal syndrome phenotype (PSP-CBS). Background: Underlying pathologies of CBS…
  • 2017 International Congress

    Suicide in Parkinson disease

    W. Li, H. Seah, L. Ng, Y. Tay, L. Au, L. Tan (Singapore, Singapore)

    Objective: This study was carried out to analyze the suicide rate in our Parkinson disease (PD)  population and review the clinical profiles of patients who…
  • 2017 International Congress

    Mindfulness for People with Parkinson’s: Emotional Well Being, Social Support and Group Effect

    B. Pickut, S. Woolner, R. Nyenhuis, D. Nyenhuis (Grand Rapids, MI, USA)

    Objective: ObjectiveTo investigate the effects of a 8-week MBSR group training on the quality of life of People with Parkinson's (PwP). Background: Little is known…
  • 2017 International Congress

    Differences in the oscillatory activity of the globus pallidus in dystonia, parkinson´s disease and gilles de la tourette syndrome

    M.M. Carmona-Abellan, M. Valencia, J. Guridi, R. Luquin, J. Artieda, M. Alegre (Pamplona, Spain)

    Objective: To compare local field potentials features in Parkinson´s disease (PD), dystonia and Gilles de la Tourette syndrome (GTS) recorded from the Globus Pallidus internus…
  • 2017 International Congress

    How efficient is subthalamic deep brain stimulation in reducing dyskinesia in Parkinson’s Disease?

    N. Kovacs, A. Juhász, I. Balás (Pecs, Hungary)

    Objective: The aim of this study was to determine whether the UDysRS can detect improvement in dyskinesia reliably after bilateral subthalamic nucleus DBS for PD.…
  • 2017 International Congress

    Neuropsychological predictors of patient-reported cognitive outcomes following deep brain stimulation

    K. Mills, K. Donohue, A. Swaminathan, J.-M. Leoutsakos, J. Brandt (Baltimore, MD, USA)

    Objective: To identify preoperative cognitive performance measures associated with patient- and/or caregiver-reported cognitive decline following deep brain stimulation (DBS) surgery for movement disorders. Background: Patients…
  • 2017 International Congress

    Cognitive effects of GPi versus STN deep brain stimulation in Parkinson’s Disease: experience with patients with moderate cognitive impairment

    C. Marques-Matos, C. Sousa, J. Lima, P. Monteiro, P. Linhares, R. Vaz, M.J. Rosas (Porto, Portugal)

    Objective: To compare the cognitive effects of GPi versus STN deep brain stimulation for PD in patients with moderate cognitive impairment. Background: Patients with moderate…
  • 2017 International Congress

    Electrode Impedance as a marker for “on” and “off” states in a Deep Brain Stimulation cohort: A pilot study

    W. Deeb, J. Shute, M. Okun (Gainesville, FL, USA)

    Objective: To determine the possible use of electrical impedance as an easily measured surrogate measure for clinical changes in patients with Parkinson’s disease (PD) with…
  • 2017 International Congress

    Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease

    L. Kirkpatrick, Y. Torres-Yaghi, A. Keys, N. Starr, T. Kimbason, C. Moussa, F. Amjad, F. Pagan (Washington, DC, USA)

    Objective: We report a case of a patient with advanced PD who began LCIG for refractory motor fluctuations while continuing longstanding STN-DBS. Background: LCIG and…
  • 2017 International Congress

    Prevalence of Parkinson’s disease and Drug-induced Parkinsonism from National Health Insurance Service Claims Data (NHISCD)

    H.-I. MA, S. Jang, J.-s. Kim, S.J. Chung, J.S. Baik, Y.J. Kim (Anyang, Republic of Korea)

    Objective: To evaluate the prevalence and characteristics of of drug induced parkinsonism Background: Drug induced parkinsonism (DIP) is a clinically important disease because it can…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley